Wells Fargo
NAUT icon

Wells Fargo’s Nautilus Biotechnolgy NAUT Stock Holding History

Wells Fargo’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79K Buy
42,268
+42,008
+16,157% +$111K ﹤0.01% 5599
2026
Q1 		$1.01K Sell
260
-300
-54% -$737 ﹤0.01% 6332
2025
Q4 		$1.09K Hold
560
– – ﹤0.01% 6280
2025
Q3 		$473 Sell
560
-883
-61% -$649 ﹤0.01% 6298
2025
Q2 		$1.04K Sell
1,443
-28,099
-95% -$21.1K ﹤0.01% 6302
2025
Q1 		$25.4K Buy
29,542
+646
+2% +$960 ﹤0.01% 5627
2024
Q4 		$48.5K Buy
28,896
+2,864
+11% +$6.85K ﹤0.01% 5494
2024
Q3 		$74.2K Buy
26,032
+4,326
+20% +$11.2K ﹤0.01% 5182
2024
Q2 		$50.8K Buy
21,706
+3,565
+20% +$9.31K ﹤0.01% 5285
2024
Q1 		$53.3K Buy
18,141
+2,291
+14% +$6.5K ﹤0.01% 5234
2023
Q4 		$47.4K Buy
15,850
+3,070
+24% +$8.78K ﹤0.01% 5296
2023
Q3 		$40.4K Sell
12,780
-6,750
-35% -$22K ﹤0.01% 5292
2023
Q2 		$75.6K Buy
19,530
+10,739
+122% +$30.9K ﹤0.01% 5205
2023
Q1 		$24.4K Buy
8,791
+8,491
+2,830% +$17.8K ﹤0.01% 5562
2022
Q4 		$540 Sell
300
-137
-31% -$264 ﹤0.01% 6368
2022
Q3 		$1K Sell
437
-492
-53% -$1.24K ﹤0.01% 6402
2022
Q2 		$3K Buy
929
+629
+210% +$2.34K ﹤0.01% 6196
2022
Q1 		$1K Hold
300
– – ﹤0.01% 6832
2021
Q4 		$2K Sell
300
-312
-51% -$1.67K ﹤0.01% 6899
2021
Q3 		$4K Buy
612
+312
+104% +$2.49K ﹤0.01% 6442
2021
Q2 		$3K Sell
300
-100
-25% -$1.08K ﹤0.01% 6470
2021
Q1 		$6K Buy
+400
New +$5.54K ﹤0.01% 6458

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Wells Fargo's NAUT Position: Q2 2026 in Review

Wells Fargo increased its Nautilus Biotechnolgy (NAUT) stake by 16,157% in Q2 2026, buying an estimated $111K and bringing the position to 42,268 shares worth $79K. The position accounts for ﹤0.01% of the portfolio, ranked #5599.

Wells Fargo first reported a position in NAUT in Q1 2021 and has held it in 22 quarters since. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Wells Fargo held 42,268 shares of Nautilus Biotechnolgy worth $79K as of Q2 2026.
  • Wells Fargo bought 42,008 Nautilus Biotechnolgy shares in Q2 2026, an estimated $111K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5599 holding.
  • Wells Fargo first reported a position in Nautilus Biotechnolgy in Q1 2021 and has held it in 22 quarters since.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.